ADRB1

adrenergic, beta-1-, receptor

ADRB1; adrenergic, beta-1-, receptor; beta-1 adrenergic receptor; ADR B1; ADRB 1; ADRB1_HUMAN; ADRB1R; Adrenergic beta 1 receptor; B1AR; Beta 1 adrenoceptor; Beta 1 adrenoreceptor; Beta-1 adrenoceptor; Beta-1 adrenoreceptor; BETA1AR; RHR;

ADRA1A

adrenergic, alpha-1A-, receptor

ADRA1A; adrenergic, alpha-1A-, receptor; alpha-1A adrenergic receptor; ADA1A_HUMAN; Adra1c; ADRA1L1; Adrenergic alpha1A receptor; Adrenergic alpha1C receptor; Adrenergic receptor alpha 1a; Adrenergic receptor alpha 1c; Alpha 1A adrenoreceptor; Alpha 1C adrenergic receptor; Alpha-1A adrenoceptor; Alpha-1A adrenoreceptor; Alpha-1C adrenergic receptor; Alpha-adrenergic receptor 1c; Alpha1A adrenergic receptor; ALPHA1AAR; alpha 1A-adrenoceptor; alpha 1A-adrenoreceptor; adrenergic, alpha 1A, receptor; adrenergic, alpha 1C, receptor;

ADRBK1

adrenergic, beta, receptor kinase 1

ADRBK1; adrenergic, beta, receptor kinase 1; beta-adrenergic receptor kinase 1; BARK1; GRK2; beta-ARK-1; G-protein coupled receptor kinase 2; BETA-ARK1; FLJ16718;

CHRM2

cholinergic receptor, muscarinic 2

CHRM2; cholinergic receptor, muscarinic 2; HM2; FLJ43243; MGC120006; MGC120007; muscarinic acetylcholine receptor M2; 7TM receptor; OTTHUMP00000208393; OTTHUMP00000208394; OTTHUMP00000208395; OTTHUMP00000208396; muscarinic M2 receptor; cholinergic receptor, muscarinic 2, isoform a; Muscarinic receptors; mAChRs;

CHRNB1

cholinergic receptor, nicotinic, beta 1 (muscle)

CHRNB1; cholinergic receptor, nicotinic, beta 1 (muscle); acetylcholine receptor subunit beta; Acetylcholine receptor protein beta chain precursor; ACHB_HUMAN; ACHRB; Cholinergic receptor nicotinic beta polypeptide 1 (muscle); Chrnb 1; CHRNB; CMS1D; CMS2A; Nicotinic acetylcholine receptor beta subunit precursor; SCCMS; cholinergic receptor, nicotinic, beta polypeptide 1 (muscle);

ERG

v-ets avian erythroblastosis virus E26 oncogene homolog

ERG; v-ets avian erythroblastosis virus E26 oncogene homolog; p55; erg-3; transcriptional regulator ERG; ets-related; TMPRSS2/ERG fusion; v-ets erythroblastosis virus E26 oncogene like; v-ets erythroblastosis virus E26 oncogene homolog; v-ets avian erythroblastosis virus E26 oncogene related; transcriptional regulator ERG (transforming protein ERG);

P2RX5

purinergic receptor P2X, ligand-gated ion channel, 5

P2RX5; purinergic receptor P2X, ligand-gated ion channel, 5; P2X purinoceptor 5; P2X5; ATP receptor; ATP receptor subunit; ionotropic ATP receptor P2X5; MGC47755; P2X5R; Purinergic receptor; Purinergic receptor P2X ligand gated ion channel 5; OTTHUMP00000115870; OTTHUMP00000241718; OTTHUMP00000241719; OTTHUMP00000241720; OTTHUMP00000241722; OTTHUMP00000241723; lymphoid-restricted histocompatibility antigen-1; LRH-1;

P2RY6

pyrimidinergic receptor P2Y, G-protein coupled, 6

P2RY6; pyrimidinergic receptor P2Y, G-protein coupled, 6; P2Y purinoceptor 6; P2Y6; G coupled nucleotide receptor; G protein coupled 6; MGC15335; P2 purinoceptor; P2RY6_HUMAN; P2Y6 receptor; PP2891; Purinergic receptor P2Y6; pyrimidinergic receptor P2Y; OTTHUMP00000237497; OTTHUMP00000237500; OTTHUMP00000237501; OTTHUMP00000237502; OTTHUMP00000237504; OTTHUMP00000237505; OTTHUMP00000237506; G-coupled nucleotide receptor;

CHRNA1

cholinergic receptor, nicotinic, alpha 1 (muscle)

CHRNA1; cholinergic receptor, nicotinic, alpha 1 (muscle); cholinergic receptor, nicotinic, alpha polypeptide 1 (muscle) , CHRNA; acetylcholine receptor subunit alpha; acetylcholine receptor; nicotinic; alpha 1 (muscle); nicotinic cholinergic receptor alp;

CHRNA4

cholinergic receptor, nicotinic, alpha 4

CHRNA4; EBN; BFNC; EBN1; NACHR; NACRA4; NACHRA4; FLJ95812; ENFL1; cholinergic receptor, nicotinic, alpha 4; neuronal acetylcholine receptor subunit alpha-4; OTTHUMP00000031784; cholinergic receptor, nicotinic, alpha polypeptide 4; neuronal nicotinic acetylcholine receptor alpha-4 subunit;

CHRNA5

cholinergic receptor, nicotinic, alpha 5

CHRNA5; LNCR2; cholinergic receptor, nicotinic, alpha 5; neuronal acetylcholine receptor subunit alpha-5; OTTHUMP00000185019; neuronal nicotinic acetylcholine receptor, alpha5 subunit; Cholinergic receptor, neuronal nicotinic, alpha polypeptide-5;

CHRNB3

CHRNB3 cholinergic receptor, nicotinic, beta 3

CHRNB3; cholinergic receptor, nicotinic, beta 3; neuronal acetylcholine receptor subunit beta-3; OTTHUMP00000229136; cholinergic receptor, nicotinic, beta polypeptide 3; acetylcholine receptor, neuronal nicotinic, beta-3 subunit;

CHRND

cholinergic receptor, nicotinic, delta

CHRND; cholinergic receptor, nicotinic, delta; ACHRD, cholinergic receptor, nicotinic, delta polypeptide; acetylcholine receptor subunit delta; Acetylcholine receptor delta subunit; ACHD_HUMAN; ACHRD; Cholinergic receptor, nicotinic, delta polypeptide; CMS2A; FCCMS; HGNC:1965; Nicotinic acetylcholine receptor delta polypeptide precursor; SCCMS; OTTHUMP00000164360;

CHRNE

cholinergic receptor, nicotinic, epsilon

CHRNE; cholinergic receptor, nicotinic, epsilon; cholinergic receptor, nicotinic, epsilon polypeptide; acetylcholine receptor subunit epsilon; ACHRE; ACHE_HUMAN; AchR epsilon subunit; CMS1D; CMS1E; CMS2A; FCCMS; SCCMS;

P2RY1

purinergic receptor P2Y, G-protein coupled, 1

P2RY1; purinergic receptor P2Y, G-protein coupled, 1; P2Y purinoceptor 1; P2Y1; ATP receptor; platelet ADP receptor; P2 purinoceptor subtype Y1;

SLC22A4

solute carrier family 22 (organic cation/ergothioneine transporter), member 4

SLC22A4; solute carrier family 22 (organic cation/ergothioneine transporter), member 4; solute carrier family 22 member 4; MGC34546; OCTN1; LSTP Like 2; MGC40524; Ergothioneine transporter; ET transporter; Organic cation transporter 1; Organic cation/carnitine transporter 1; RP23-354D12.1; S22A4_HUMAN; Solute carrier family (organic cation transporter), member 4; integral membrane transport protein;

SRGN

serglycin

SRGN; serglycin; PRG, PRG1, proteoglycan 1, secretory granule; PPG; serglycin proteoglycan; Chondroitin sulfate proteoglycan core protein; Cytolytic granule proteoglycan core protein; FLJ12930; gp600; Hematopoetic proteoglycan core protein; Mastocytoma proteoglycan core protein; MGC9289; OTTHUMP00000019716; P.PG; PG19 core protein; Pgsg; Platelet proteoglycan core protein; platelet proteoglycan protein core; PRG; PRG1; PROTEOGLYCAN 1; proteoglycan 1, secretory granule; Proteoglycan 10K core protein; Proteoglycan peptide core protein; PROTEOGLYCAN PROTEIN CORE FOR MAST CELL SECRETORY GRANULE; secretory granule proteoglycan 1; Secretory granule proteoglycan core protein; Sgc; SRGN_HUMAN; hematopoetic proteoglycan core peptide; secretory granule proteoglycan core peptide; secreto;

ADRBK2

adrenergic, beta, receptor kinase 2

ADRBK2; adrenergic, beta, receptor kinase 2; beta-adrenergic receptor kinase 2; BARK2; GRK3; beta-ARK-2; G-protein-coupled receptor kinase 3;

CHRNG

cholinergic receptor, nicotinic, gamma

CHRNG; cholinergic receptor, nicotinic, gamma; ACHRG, cholinergic receptor, nicotinic, gamma polypeptide; acetylcholine receptor subunit gamma; Acetylcholine receptor muscle gamma subunit; Acetylcholine receptor protein gamma chain precursor; ACHG; Achr 3; Achr3; ACHRG; ACRG; Cholinergic receptor nicotinic gamma; Cholinergic receptor nicotinic gamma polypeptide; MGC133376; OTTHUMP00000203703; OTTHUMP00000203704; acetylcholine receptor, muscle, gamma subunit; cholinergic receptor, nicotinic, gamma polypeptide;

P2RX7

P2rx7 purinergic receptor P2X, ligand-gated ion channel, 7

P2RX7; purinergic receptor P2X, ligand-gated ion channel, 7; P2X purinoceptor 7; ATP receptor; P2Z receptor; P2X7 purinoceptor; purinergic receptor P2X7;

P2RY13

purinergic receptor P2Y, G-protein coupled, 13

P2RY13; purinergic receptor P2Y, G-protein coupled, 13; G protein coupled receptor 86 , GPR86, GPR94; P2Y purinoceptor 13; FKSG77; P2Y13; G protein coupled receptor 86; G protein coupled receptor 94; G-protein coupled receptor 86; G-protein coupled receptor 94; GPCR1; GPR86; GPR94; HGNC:13661; P2Y13_HUMAN; Purinergic receptor P2Y G protein coupled 13; SP174; OTTHUMP00000208577; G protein-coupled receptor 86;

CHRNA7

cholinergic receptor, nicotinic, alpha 7 (neuronal)

CHRNA7; cholinergic receptor, nicotinic, alpha 7 (neuronal); NACHRA7; CHRNA7-2; neuronal acetylcholine receptor subunit alpha-7; a7 nicotinic acetylcholine receptor; alpha-7 nicotinic cholinergic receptor subunit; alpha 7 neuronal nicotinic acetylcholine receptor; cholinergic receptor, nicotinic, alpha polypeptide 7; neuronal acetylcholine receptor protein, alpha-7 chain;

CHRNA2

cholinergic receptor, nicotinic, alpha 2 (neuronal)

CHRNA2; cholinergic receptor, nicotinic, alpha 2 (neuronal); cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal); neuronal acetylcholine receptor subunit alpha-2; ACHA2_HUMAN; Cholinergic receptor nicotinic alpha 2; Neuronal acetylcholine receptor protein subunit alpha 2;

P2RX3

purinergic receptor P2X, ligand-gated ion channel, 3

P2RX3; purinergic receptor P2X, ligand-gated ion channel, 3; P2X3; P2X purinoceptor 3; ATP receptor; purinoceptor P2X3; P2X receptor, subunit 3; purinergic receptor P2X3;

ADRB3

adrenergic receptor, beta 3

ADRB3; adrenergic receptor, beta 3; beta-3 adrenergic receptor; ADR B3; ADRB 3; ADRB3_HUMAN; ADRB3R; Adrenergic beta 3 receptor; B3AR; Beta 3 adrenoceptor; Beta 3 adrenoreceptor; Beta 3AR; Beta-3 adrenoceptor; Beta-3 adrenoreceptor; Beta3AR; FLJ99960; Beta-3 AR; beta 3-AR; OTTMUSP00000036279; beta3-adrenergic receptor; Adrb-3;

CHRM3

cholinergic receptor, muscarinic 3

CHRM3; cholinergic receptor muscarinic 3; CHRM 3; HM3; M3 muscarinic receptor; muscarinic 3; Muscarinic M3 Receptor (a.a. 580-589); Muscarinic M3 Receptor; muscarinic acetylcholine receptor M3; OTTHUMP00000037632;

ADRA1B

adrenergic, alpha-1B-, receptor

ADRA1B; adrenergic, alpha-1B-, receptor; alpha-1B adrenergic receptor; alpha-1B adrenoceptor; alpha-1B adrenoreceptor; alpha-1B-adrenergic receptor; ADRA1; ALPHA1BAR;

ADRA2B

adrenergic receptor, alpha 2b

ADRA2B; adrenergic receptor, alpha 2b; alpha-2B adrenergic receptor; alpha-2BAR; subtype alpha2-C2; alpha-2B adrenoceptor; alpha-2B adrenoreceptor; [a]2B; Adra-2b; alpha2B; alpha2-C2;

CHRNA10

cholinergic receptor, nicotinic, alpha 10

CHRNA10; cholinergic receptor, nicotinic, alpha 10; cholinergic receptor, nicotinic, alpha polypeptide 10; neuronal acetylcholine receptor subunit alpha-10; Acetylcholine receptor, neuronal nicotinic, alpha-10 subunit; ACH10_HUMAN; Alpha 10 nAChR; Cholinergic receptor nicotinic alpha 10; Cholinergic receptor, neuronal nicotinic, alpha polypeptide 10; CHRNA 10; NACHR alpha 10; NACHR alpha-10; NACHRA10; Neuronal acetylcholine receptor protein subunit alpha 10; Nicotinic acetylcholine receptor subunit alpha 10; Nicotinic acetylcholine receptor subunit alpha-10; OTTHUMP00000013620;

CHRNA6

cholinergic receptor, nicotinic, alpha 6

CHRNA6; cholinergic receptor, nicotinic, alpha 6; cholinergic receptor, nicotinic, alpha polypeptide 6; neuronal acetylcholine receptor subunit alpha-6; Cholinergic receptor nicotinic alpha 6; Cholinergic receptor nicotinic alpha polypeptide 6; CHRNA 6; Neuronal acetylcholine receptor subunit alpha 6; CHNRA6;

CHRFAM7A

CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion

CHRFAM7A; CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion; CHRNA7-FAM7A fusion protein; CHRNA7 DR1; D 10; Alpha 7 neuronal nicotinic acetylcholine receptor FAM7A hybrid; CHRNA7 (cholinergic receptor nicotinic alpha 7 exons 5 10) and FAM7A (family with sequence similarity 7A exons A E) fusion; CHRNA7; CHRNA7 FAM7A fusion; CHRNA7 FAM7A fusion protein; D10; HGNC:15781; MGC120482; MGC120483; alpha-7 nicotinic cholinergic receptor subunit; alpha 7 neuronal nicotinic acetylcholine receptor-FAM7A hybrid; CHRNA7 (cholinergic receptor, nicotinic, alpha polypeptide 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion; D-10; CHRNA7-DR1;

ERGIC3

ERGIC and golgi 3

ERGIC3; ERGIC and golgi 3; C20orf47, chromosome 20 open reading frame 47 , SDBCAG84, serologically defined breast cancer antigen 84; endoplasmic reticulum-Golgi intermediate compartment protein 3; CGI 54; Erv46; NY BR 84; PRO0989; endoplasmic reticulum-;

RERGL

RERG/RAS-like

RERGL; RERG/RAS-like; ras-related and estrogen-regulated growth inhibitor-like protein; FLJ22655; Clone HSI07590; Hypothetical protein FLJ22655; Hypothetical protein LOC79785; Putative uncharacterized protein FLJ22655; Ras related and estrogen-regulated growth inhibitor like protein; RERG/Ras like; RERG/Ras like protein; RERG/Ras-like protein;

HDX

highly divergent homeobox

HDX; highly divergent homeobox; chromosome X open reading frame 43 , CXorf43; FLJ30678; CXorf43; D030011N01Rik; MGC126769; MGC126771; OTTHUMP00000062139;

CHRM4

cholinergic receptor, muscarinic 4

Cholinergic Receptor Muscarinic 4; Chrm 4; CHRM4; HM 4; HM4; M4; cholinergic receptor, muscarinic 4; M4R; Muscarinic M4 Receptor; OTTHUMP00000205575; muscarinic acetylcholine receptor M4;

CHRM5

cholinergic receptor, muscarinic 5

CHRM5; cholinergic receptor, muscarinic 5; HM5; MGC41838; muscarinic acetylcholine receptor M5; OTTHUMP00000159731;

CHRNB4

cholinergic receptor, nicotinic, beta 4

neuronal acetylcholine receptor subunit beta-4; CHRNB4; OTTHUMP00000185021; neuronal nicotinic receptor beta 4 subunit; cholinergic receptor, nicotinic, beta polypeptide 4; cholinergic receptor, nicotinic, beta 4; ACHB4_HUMAN; Cholinergic receptor nicotinic beta 4; Cholinergic receptor nicotinic beta polypeptide 4; Nicotinic beta 4 Receptor;

P2RX1

purinergic receptor P2X, ligand-gated ion channel, 1

P2RX1; purinergic receptor P2X, ligand-gated ion channel, 1; P2X1; P2X purinoceptor 1; ATP receptor; P2X1 receptor; P2X receptor, subunit 1; purinergic receptor P2X1;

CHRNA3

cholinergic receptor, nicotinic, alpha 3

CHRNA3; cholinergic receptor, nicotinic, alpha 3; cholinergic receptor, nicotinic, alpha polypeptide 3; NACHRA3; LNCR2; PAOD2; MGC104879; neuronal acetylcholine receptor subunit alpha-3; neuronal nicotinic acetylcholine receptor, alpha3 subunit; OTTHUMP00000185024; OTTHUMP00000185025;

P2RX2

purinergic receptor P2X, ligand-gated ion channel, 2

P2RX2; purinergic receptor P2X, ligand-gated ion channel, 2; P2X2; DFNA41; P2X purinoceptor 2; ATP receptor; P2X Receptor, subunit 2;

P2RX4

purinergic receptor P2X, ligand-gated ion channel, 4

P2RX4; purinergic receptor P2X, ligand-gated ion channel, 4; P2X4; P2X4R; P2X purinoceptor 4; ATP receptor; purinoceptor P2X4; P2X receptor, subunit 4; purinergic receptor P2X4; ATP-gated cation channel protein;

P2RX6

purinergic receptor P2X, ligand-gated ion channel, 6

P2RX6; purinergic receptor P2X, ligand-gated ion channel, 6; P2RXL1, purinergic receptor P2X like 1, orphan receptor; P2X purinoceptor 6; MGC129625; P2X6; P2XM; ATP receptor; P2RXL1; Purinergic receptor; Purinergic receptor P2X like 1; Skeletal muscle expressed P2X; purinoceptor P2X6; purinoreceptor P2X6; skeletal muscle-expressed P2X; purinergic receptor P2X-like 1, orphan receptor;

P2RY11

purinergic receptor P2Y, G-protein coupled, 11

P2RY11; purinergic receptor P2Y, G-protein coupled, 11; P2Y purinoceptor 11; P2Y11; P2Y11 receptor; Purinergic receptor P2Y G protein coupled 11; Purinergic receptor P2Y11;

P2RY12

purinergic receptor P2Y, G-protein coupled, 12

P2RY12; purinergic receptor P2Y, G-protein coupled, 12; P2Y purinoceptor 12; HORK3; P2Y12; SP1999; ADP-glucose receptor; purinergic receptor P2RY12; P2Y12 platelet ADP receptor; Gi-coupled ADP receptor HORK3; G-protein coupled receptor SP1999; putative G-;

P2RY4

pyrimidinergic receptor P2Y, G-protein coupled, 4

P2RY4; pyrimidinergic receptor P2Y, G-protein coupled, 4; P2Y purinoceptor 4; NRU; Nucleotide receptor uridine; P2P; P2Y4; P2Y4R; Pyrimidinergic receptor P2Y G protein coupled 4; UNR; Uridine nucleotide receptor; P2Y4 receptor; purinergic receptor P2Y, G-protein coupled, 4;

SC5DL

sterol-C5-desaturase (ERG3 delta-5-desaturase homolog, S. cerevisiae)-like

SC5DL; sterol-C5-desaturase (ERG3 delta-5-desaturase homolog, S. cerevisiae)-like; sterol C5 desaturase (ERG3 delta 5 desaturase homolog, fungal) like , sterol C5 desaturase (fungal ERG3, delta 5 desaturase) like; lathosterol oxidase; S5DES; 3beta hydroxysteroid delta5 desaturase; C 5 sterol desaturase; Delta 5 desaturase like; Delta(7) sterol 5 desaturase; ERG3; Fungal ERG3; Lathosterol 5 desaturase; MGC93101; SC5D; Sterol C5 desaturase (ERG3 delta 5 desaturase homolog, S. cerevisiae) like; Sterol C5 desaturase; C-5 sterol desaturase; lathosterol 5-desaturase; lathosterol dehydrogenase; delta(7)-sterol 5-desaturase; fungal ERG3, delta-5-desaturase-like; 3beta-hydroxysteroid-delta5-desaturase;

ADRA2C

adrenergic, alpha-2C-, receptor

ADRA2C; adrenergic, alpha-2C-, receptor; ADRA2L2, ADRA2RL2; alpha-2C adrenergic receptor; ADRARL2; alpha-2CAR; alpha2-AR-C4; alpha-2C adrenoceptor; alpha-2C adrenoreceptor; alpha-2C-adrenergic receptor; alpha-2 adrenergic receptor subtype C4; ADRA2L2; ADR;

CHRM1

cholinergic receptor, muscarinic 1

Cholinergic receptor muscarinic 1; CHRM1; HM1; M1; Muscarinic acetylcholine receptor M1; cholinergic receptor, muscarinic 1; OTTHUMP00000236792; M1R; MGC30125; Muscarinic M1 Receptor;

CHRNB2

cholinergic receptor, nicotinic, beta 2 (neuronal)

Acetylcholine receptor beta 2 neural; ACHB2_HUMAN; ACHN; Acrb 2; Acrb2; b2 nAchR; Cholinergic receptor nicotinic beta 2; Cholinergic receptor nicotinic beta polypeptide 2; Cholinergic receptor nicotinic beta polypeptide 2 neuronal; CHRNB2; EFNL 3; EFNL3; nAChRB2; Neuronal acetylcholine receptor protein beta 2 chain precursor; Neuronal acetylcholine receptor protein subunit beta 2; Neuronal acetylcholine receptor subunit beta-2; Neuronal nicotinic acetylcholine receptor beta 2; cholinergic receptor, nicotinic, beta 2 (neuronal); cholinergic receptor, nicotinic, beta polypeptide 2 (neuronal); Nicotinic beta 2 Receptor; OTTHUMP00000035374; Nicotinic beta 2 (carboxyl terminal) Receptor;

P2RY14

purinergic receptor P2Y, G-protein coupled, 14

P2RY14;purinergic receptor P2Y, G-protein coupled, 14;16442;ENSG00000174944;P2Y14;GPR105;3q24-q25.1;KIAA0001;P2Y purinoceptor 14;P2Y purinoceptor 14;P2Y14 receptor;P2Y(14) receptor;UDP-glucose receptor;G protein-coupled receptor 105;G-protein coupled receptor 105;G protein coupled receptor for UDP-glucose;

P2RY2

purinergic receptor P2Y, G-protein coupled, 2

purinergic receptor P2Y, G-protein coupled, 2; P2U; HP2U; P2U1; P2UR; P2Y2; P2RU1; P2Y2R; P2Y purinoceptor 2; ATP receptor; P2U purinoceptor 1; P2U nucleotide receptor; purinergic receptor P2Y2; OTTHUMP00000237494; OTTHUMP00000237495; OTTHUMP00000237496; MGC20088; purinoceptor P2Y2; MGC40010; Purinergic receptor;

ADRA2A

Adrenergic, Alpha-2A-, Receptor

Adra2a; adrenergic, alpha-2A-, receptor; RG20; CA2-47; RATRG20; adrenergic receptor, alpha 2a; Adrenergic alpha 2A receptor; Adrenergic, alpha 2A, receptor; alpha-2AAR; alpha-2A adrenoceptor; alpha-2A adrenoreceptor; alpha-2A adrenergic receptor; alpha-2D adrenergic receptor;

SYNRG

synergin, gamma

SYNRG;synergin, gamma;557;ENSG00000006114;SYNG;AP1GBP1;17q12;FLJ34482, MGC104959;synergin gamma;synergin gamma;gamma-synergin;AP1 gamma subunit binding protein 1;AP1 subunit gamma-binding protein 1;adaptor-related protein complex 1 gamma subunit-binding protein 1;

DPRX

divergent-paired related homeobox

DPRX;divergent-paired related homeobox;32166;ENSG00000204595;19q13.42;divergent paired-related homeobox;divergent paired-related homeobox;

ENHO

energy homeostasis associated

ENHO;energy homeostasis associated;24838;ENSG00000168913;UNQ470;C9orf165;9p13.3;adropin;adropin;GAAI470;energy homeostasis-associated protein;

ERGIC1

endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1

ERGIC1;endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1;29205;ENSG00000113719;NET24;ERGIC32;ERGIC-32;5q35.1;FLJ39864, KIAA1181, MGC14345;endoplasmic reticulum-Golgi intermediate compartment protein 1;endoplasmic reticulum-Golgi intermediate compartment protein 1;ER-Golgi intermediate compartment 32 kDa protein;endoplasmic reticulum-golgi intermediate compartment 32 kDa protein;

ERGIC2

ERGIC and golgi 2

ERGIC2;ERGIC and golgi 2;30208;ENSG00000087502;PTX1;CDA14;Erv41;cd002;12p11.22;MGC111152;endoplasmic reticulum-Golgi intermediate compartment protein 2;endoplasmic reticulum-Golgi intermediate compartment protein 2;CD14 protein;

CHRNA9

cholinergic receptor, nicotinic, alpha polypeptide 9

Acra9; Gm8311; EG666827; 2410015I05Rik;

P2RY10

purinergic receptor P2Y, G-protein coupled, 10

P2RY10; Putative P2Y purinoceptor 10; P2Y-like receptor;

Sc5d

sterol-C5-desaturase (fungal ERG3, delta-5-desaturase) homolog (S. cerevisae)

Sc5dl; A830037K02; A830073K23Rik;

LINC00341

LINC00341 long intergenic non-protein coding RNA 341 [ Homo sapiens (human) ]

long intergenic non-protein coding RNA 341; C14orf139; NCRNA00341; chromosome 14 open reading frame 139; non-protein coding RNA 341;

LINC00597

LINC00597 long intergenic non-protein coding RNA 597 [ Homo sapiens (human) ]

long intergenic non-protein coding RNA 597; C15orf5; chromosome 15 open reading frame 5; LINC00597;

LINC00478

LINC00478 long intergenic non-protein coding RNA 478 [ Homo sapiens (human) ]

C21orf34; C21orf35; FLJ38295; LINC00478; long intergenic non-protein coding RNA 478;

LINC00313

LINC00313 long intergenic non-protein coding RNA 313 [ Homo sapiens (human) ]

C21orf84; NCRNA00313; long intergenic non-protein coding RNA 313; chromosome 21 open reading frame 84; non-protein coding RNA 313;

Detergent Micelle Platform

Proteins are inserted in lipid bilayers through hydrophobic interactions between lipid tails and hydrophobic protein structural domains. These integral membrane proteins are insoluble in aqueous solution and are aggregated. However, they can be soluble in descaling agents, which form micelles simila...

Rescue Me from the Peanut Allergy by Inhibiting Pim 1 and Runx3?

In the newly 2012 Journal of Allergy and Clinical Immunology, Erwin Gelfand, MD, and his colleagues at National Jewish Health reported that levels of the enzyme Pim 1 kinase rise in the small intestines of peanut-allergic mice and inhibiting activity of Pim 1 markedly reduced the allergic response...

Researchers Discovered the Energy and Pathway of Opening and Closing of Ion Channel

Ion channelsare pore-formingmembraneproteins. They are important components in many biological processes that involve rapid changes in cells, for example,cardiac,skeletal, andsmooth musclecontraction,epithelialtransport of nutrients and ions,T-cellactivation andpancreaticbeta-cellinsulinrele...

Retrospective Viewpoint: Biotechnology Companies Keep Going with Mergers

In face of patent expiration or other threats, big pharmaceutics are facing challenges too. In priority, innovative technology or novel developments are necessary. On 2010, Celgene declared the acquisition of ABII for $2.9 billion for cancer treatment. ...

The Biosimilar Industry Emerging Trends in Asia

At the time when biosimilars market development in the U.S. and Europe still looks a little hazy to analysts, and still many people are thinking over and surprising at how quickly these biologic knockoffs can muscle aside some powerhouse competition from well-known brands. In Asia, multi...